Physician profile
Dinesh Sharma
NPI 1376731406
$145,498.39
in general payments reported to CMS, 2019-2025
26 companies · $60K in 2025
The $60K reported for 2025 was more than what 96% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $517 · 2020: $227 · 2021: $6,592 · 2022: $35K · 2023: $16K · 2024: $26K · 2025: $60K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $37K · Consulting Fee: $34K · Travel and Lodging: $18K · Food and Beverage: $13K · Honoraria: $1,200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $36,725.00 |
| Consulting Fee | $34,075.00 |
| Travel and Lodging | $18,232.98 |
| Food and Beverage | $12,847.84 |
| Honoraria | $1,200.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $58,529.77 | 2021-2025 | Affera Mapping System, Pulseselect, Cobalt Dr Mri Surescan |
| Biosense Webster, INC. | $43,480.23 | 2019-2025 | Carto 3, Thermocool Sf, Thermocool Smarttouch |
| Boston Scientific Corporation | $18,231.88 | 2019-2025 | Farapulse, General - Therapies, Watchman Flx |
| Medical Device Business Services, INC. | $9,750.00 | 2024 | Carto 3 |
| Abbott Laboratories | $5,302.76 | 2019-2025 | Amplatzer Amulet, Ensite, Absolute Pro |
| Altathera Pharmaceuticals LLC | $4,119.75 | 2023-2025 | Sotalol Hydrochloride |
| Haemonetics Corporation | $1,717.06 | 2024 | Ensoetm |
| Philips North America LLC | $1,181.79 | 2024-2025 | Lm Undivided, Fleet Management, Igt Devices Undivided |
| Cardiva Medical, INC. | $696.11 | 2020-2025 | Savvywire, Cardiva Vascade Mvp Vvcs 6-12f |
| Abiomed | $555.48 | 2023-2024 | Impella |
| W. L. Gore & Associates, INC. | $326.55 | 2020-2022 | |
| Cvrx, INC. | $324.97 | 2021-2025 | Barostim Neo System |
| Atricure, INC. | $252.90 | 2024-2025 | Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System |
| Impulse Dynamics (USA) INC. | $180.00 | 2024 | Optimizer |
| Baxter Healthcare | $160.80 | 2024-2025 | Floseal, Tisseel, Hillrom - Cardiac Ambulatory Monitor |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Irhythm Technologies, INC. | $100.65 | 2023 | Zio Xt Patch |
| Cardiofocus, INC. | $95.18 | 2019 | |
| Siemens Medical Solutions USA, INC. | $93.84 | 2024 | Sensis |
| Pfizer INC. | $91.21 | 2023-2025 | |
| Biotronik INC. | $90.17 | 2019 | |
| Sanofi-Aventis U.S. LLC | $68.56 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $40.14 | 2021-2025 | Lifevest |
| Inari Medical, INC. | $37.96 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Actelion Pharmaceuticals US, INC. | $28.58 | 2025 | Uptravi |
| Scpharmaceuticals INC. | $25.14 | 2024 | |
| Ebr Systems, INC. | $16.91 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$525.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dinesh Sharma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.